E7080 in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma



Status:Archived
Conditions:Skin Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:August 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7080 in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma.


Primary:

- Phase Ib: To define the safety, tolerability and maximum tolerated dose (MTD) of E7080
administered in combination with dacarbazine.

- Phase II: To evaluate the safety and tolerability of E7080 administered in combination
with dacarbazine, compared with dacarbazine alone.

Secondary:

• Phase II: to make a preliminary assessment of the efficacy of E7080 administered in
combination with dacarbazine, compared with dacarbazine alone.



We found this trial at
5
sites
New York Oncology Hematology PC-Albany
Albany, New York 12206
?
mi
from
Albany, NY
Click here to add this to my saved trials
UT Soutwestern Medical Center at Dallas
5303 Harry Hines Boulevard
Dallas, Texas 75390
(214) 648-3111
UT Soutwestern Medical Center at Dallas UT Southwestern Medical Center is distinctive for its overall...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Cancer Centers of the Carolinas - Faris Road
900 West Faris Road
Greenville, South Carolina 29605
(864) 679-3900
Cancer Centers of the Carolinas - Faris Road Cancer Centers of the Carolinas is now...
?
mi
from
Greenville, SC
Click here to add this to my saved trials
Washington County Hospital
Hagerstown, Maryland 21740
?
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Virginia Oncology Assoc.
Norfolk, Virginia 23502
?
mi
from
Norfolk, VA
Click here to add this to my saved trials